Study #2024-0145
Understanding and preventing Cortical Mechanisms of Chemotherapy-induced peripheral neuropathy
MD Anderson Study Status
Enrolling
Treatment Agent
Diagnostic Test: Electroencephalogram (EEG)
Description
Cohort 1: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN). Cohort 2: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN) and to test a certain type of experimental neuromodulation (stimulation of the brain) with a device called a closed-loop brain-computer interface (clBCI) to see if can help to prevent pain due to CIPN.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Chemotherapy-induced Peripheral Neuropathy
Study phase:
Physician name:
Sarah Prinsloo
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-855-981-0775
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.